Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it is better equipped in several technical and logistical areas than before COVID-19. Significant gaps persist in sustained funding, coordination, state-level readiness, healthcare system resilience, public trust, and full implementation of lessons learned, with recent policy shifts introducing new uncertainties.[1]
Progress Since COVID-19
The US has strengthened key capabilities based on COVID-19 experiences:
Biden-era roadmaps and reports highlighted these gains, including vaccination programs, testing scale-up, and equitable response efforts that reduced disparities in some areas during COVID recovery.[2]
Persistent Gaps and Vulnerabilities
Independent assessments consistently find the US underprepared relative to the scale of potential threats (natural, accidental, or deliberate):
Recent Developments (2025–2026 Context)
Policy shifts under the second Trump administration have mixed or concerning implications for preparedness:
Public health funding instability, workforce issues, and political polarization compound these. Joint External Evaluations (IHR) and other reviews note needs for better SLTT (state/local/tribal/territorial) alignment and capacity.[11]
Overall Assessment
The US has stronger tools for detection, stockpiling, forecasting, and countermeasure development than in early 2020, and ranks highly on capability indices. However, preparedness is incomplete and fragile: lessons from COVID (and earlier events) have been only partially learned/implemented, funding and political will fluctuate, state performance varies widely, and healthcare/public health infrastructure remains strained. Recent changes risk eroding gains in R&D platforms, global coordination, and dedicated pandemic offices.
A severe or novel pathogen (especially one with high transmissibility/severity, or concurrent with other disasters) could still overwhelm systems, particularly if trust is low or supply chains falter. Experts from bipartisan commissions, GAO, TFAH, and academia broadly agree that sustained, bipartisan investment in core public health infrastructure, stable funding, clearer authorities/coordination, domestic manufacturing, equity-focused resilience, and full recommendation implementation are essential. Without them, the US remains vulnerable—better than before, but not adequately prepared. Ongoing threats like H5N1 underscore the urgency.
Citations (11)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Significant gaps persist in sustained funding, coordination, state-level readiness, healthcare system resilience, public trust, and full implementation of lessons learned, with recent policy shifts introducing new uncertainties.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “BARDA (Biomedical Advanced Research and Development Authority) has advanced vaccines, therapeutics, and diagnostics, with ongoing work on threats like H5N1 avian influenza (including stockpiled doses and mRNA platform investments, though some of the latter faced later cuts).”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: ““Warm base” partnerships with clinical labs aim for faster test development and surge capacity.”
- https://ghsindex.org/country/united-states/
Backs: “The US typically ranks at or near the top of the Global Health Security (GHS) Index (e.g., overall scores around 83+ out of 100 in recent assessments, leading in detection/reporting and prevention categories), reflecting strong lab capacity, biosafety, and norms compliance on paper.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “A 2026 update noted continued strain from flu seasons, measles, H5N1, and weather events amid federal system pressures. All states need improvement.”
- https://www.gao.gov/assets/880/875844.pdf
Backs: “Implementation would improve future responses, but progress is incomplete.”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Funding is volatile—COVID supplemental funds expired, leading to cuts, and authorized vs. appropriated levels under PAHPA show shortfalls (e.g., multi-billion-dollar gaps projected for countermeasures).”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Other outbreaks (mpox, Marburg, measles) test systems unevenly.”
- https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives
Backs: “ASPR/BARDA advanced some medical countermeasures (new FDA approvals), SNS training/deployments for real incidents (mpox, H5N1 antivirals, etc.), and onshoring/pharma resilience efforts. Responses to certain outbreaks continued.”
- https://geneticliteracyproject.org/2026/10/26/in-trump-administration-redirect-u-s-steers-nih-sharply-away-from-biodefense-and-pandemic-preparedness/
Backs: “H5N1 and other threats have drawn criticism for inadequate control.”
- https://iris.who.int/bitstream/handle/10665/380155/9789240105409-eng.pdf?sequence=1sask
Backs: “Joint External Evaluations (IHR) and other reviews note needs for better SLTT (state/local/tribal/territorial) alignment and capacity.”